Literature DB >> 6185628

Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.

R Thorpe, P D Minor, A Mackay, G C Schild, M Spitz.   

Abstract

Investigation of the immunological reactions with individual poliovirus capsid polypeptides of antisera and monoclonal antibodies raised against poliovirus type 3 antigens are described. Virus polypeptides were separated by electrophoresis, transferred electrophoretically to nitrocellulose sheets and treated with antibody preparations. Antibody binding specifically to the virus polypeptides was then detected by application of 125I-labelled anti-immunoglobulin followed by autoradiography. The technique readily enabled the identification of the polypeptides recognized by the antibody. Antibodies present in polyclonal, type-specific neutralizing sera to poliovirus type 3 bound to the two largest capsid polypeptides (VP1 and VP2) of the homotypic poliovirus, and also to the VP1 of poliovirus type 1 and type 2. There was no obvious difference between the antibody binding patterns obtained with neutralizing and non-neutralizing antisera or between C-specific and D-specific antisera. VP1 appeared to be the immunodominant virus polypeptide. Among monoclonal antibodies specific for the C antigen of poliovirus type 3, a proportion reacted homotypically with the VP1 of poliovirus type 3. Other monoclonal antibodies of C antigen or D antigen specificity, or which reacted both with D and C antigens, some of which had potent virus-neutralizing activity, failed to give demonstrable binding reactions. The non-correlation of neutralization and immunoblot reactivity suggests that sequence determinants alone do not mediate virus neutralization which may depend on antigenic determinants specified by complex conformational arrangements of the virus capsid proteins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185628     DOI: 10.1099/0022-1317-63-2-487

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.

Authors:  K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Cross-reactions of immunoglobulin M and G antibodies with enterovirus-specific viral structural proteins.

Authors:  F Reigel; F Burkhardt; U Schilt
Journal:  J Hyg (Lond)       Date:  1985-10

3.  Intertypic cross-reactions of nonneutralizing, monoclonal poliovirus antibodies.

Authors:  R Vrijsen; B Rombaut; A Boeye
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

4.  Heterogeneity of capsid proteins of echovirus type 25 wild-type strain and prototype strain, studied by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting.

Authors:  H Peigue-Lafeuille; J L Bailly; F Fuchs; M Chambon; M Aymard
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

5.  Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus.

Authors:  A Inoue; Y K Choe; B S Kim
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

Review 6.  The application of monoclonal antibodies in the study of viruses.

Authors:  M J Carter; V ter Meulen
Journal:  Adv Virus Res       Date:  1984       Impact factor: 9.937

7.  Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays.

Authors:  Madala Uma; P P Rao; K Nagalekshmi; N R Hegde
Journal:  Protein Expr Purif       Date:  2016-08-24       Impact factor: 1.650

8.  Chapter 4 Picornavirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.